Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027078 · ClinicalTrials.gov registry record
Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 90
- Enrollment target
NCT01027078 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 90 participants.
The verdict
NCT01027078 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The investigators hypothesized that patients with Obstructive Sleep Apnea (OSA) who are free of any cardiovascular disease will have early microcirculatory changes that are unique to OSA, and therefore would resolve with treatment of OSA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2009-11 |
| Est. Completion | 2022-02-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027078
The ClinicalTrials.gov registry entry for NCT01027078 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01027078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027078 about?
NCT01027078 is a clinical study titled "Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea (OSA)". The investigators hypothesized that patients with Obstructive Sleep Apnea (OSA) who are free of any cardiovascular disease will have early microcirculatory changes that are unique to OSA, and therefore would resolve with treatment of OSA.
What is the current status of trial NCT01027078?
This trial is currently terminated. The enrollment target is 90 participants. The study started on 2009-11. Estimated completion is 2022-02-04.
Who is sponsoring clinical trial NCT01027078?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.